Professor, Medicine, Baylor College of Medicine
Cardiology
Dr. Christie M. Ballantyne, MD
|
|
Give Review
Dr. Christie M. Ballantyne is an expert in the field of Cardiology. He graduated from Baylor College of Medicine. He has 5 awards "America's Top Doctors", "Top Doctors:SE Texas", "Elected Member", "Fellow (FACC)" and "Whos Who in Medicine and Healthcare". Christie M. Ballantyne, MD is a published MD as well. He has 99 publications published. The latest was: Treatment Gaps in Adults with Heterozygous Familial Hypercholesterolemia in the United States: Data from the CASCADE-FH Registry. Christie Ballantyne is registered with Medicare.
Publications
- Case-based educational intervention to assess change in providers' knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association C...
- Genetic Testing in Hyperlipidemia.
- Calf muscle perfusion as measured with magnetic resonance imaging to assess peripheral arterial Disease.
- The impact of multiple single day blood pressure readings on cardiovascular risk estimation: The Atherosclerosis Risk in Communities study.
- Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial.
- Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein (GCKR) Inhibition: GCKR-Leu446Pro Variant in Look A...
- Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance.
- Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry.
- The promise of proprotein convertase subtilisin/kexin 9 inhibitors for the treatment of familial hypercholesterolemia.
- Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events.
- Results of Bococizumab, A Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, from a Randomized, Placebo-Controlled, Dose-Ranging Study in Stati...
- High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities study.
- Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney Disease: the Atherosclerosis Risk in Communities study.
- Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular Disease: insights from the National Cardiovascular Dis...
- Statins, plasma cholesterol, and risk of Parkinson's Disease: A prospective study.
- Development of chagas cardiac manifestations among Texas blood donors.
- High-sensitivity cardiac troponin T and the risk of incident Atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.
- Gender disparities in evidence-based statin therapy in patients with cardiovascular Disease.
- Obesity, subclinical myocardial injury, and incident Heart failure.
- Relation between playing position and coronary Artery calcium scores in retired national football league players.
- Pre-Morbid Body Mass Index and Mortality After Incident Heart Failure: The ARIC Study.
- Eligibility for Statin Therapy According to New Cholesterol Guidelines and Prevalent Use of Medication to Lower Lipid Levels in an Older US Cohort: The Atherosclerosis...
- Inflammation versus Host Defense in Obesity.
- Dual Role of the Leukocyte Integrin αMβ2 in Angiogenesis.
- Association between lipoprotein associated phospholipase A2 mass and subclinical coronary and Carotid atherosclerosis in Retired National Football League players.
- Is High-Intensity Statin Therapy Associated With Lower Statin Adherence Compared With Low- to Moderate-Intensity Statin Therapy? Implications of the 2013 American Coll...
- Diabetes mellitus, prediabetes, and incidence of subclinical Myocardial damage.
- Association of Body Mass Index and Waist Circumference with Subclinical Atherosclerosis in Retired NFL Players.
- Distribution of calcification in Carotid endarterectomy tissues: Comparison of micro-computed tomography imaging with histology.
- Antiatherosclerotic Effects of Long-Term Maximally Intensive Statin Therapy After Acute Coronary Syndrome: Insights From Study of Coronary Atheroma by Intravascular Ul...
- Sex-Related Differences of Coronary Atherosclerosis Regression Following Maximally Intensive Statin Therapy: Insights From SATURN.
- B-type natriuretic peptide and C-reactive protein in the prediction of Atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.
- Plasma Lactate and Incident Hypertension in the Atherosclerosis Risk in Communities Study.
- Validated context-dependent associations of coronary heart Disease risk with genotype variation in the chromosome 9p21 region: the Atherosclerosis Risk in Communities ...
- Lipid lowering with PCSK9 inhibitors.
- Cardiac and Kidney Markers for Cardiovascular Prediction in Individuals With Chronic Kidney Disease: The Atherosclerosis Risk in Communities Study.
- Reply: The Association between Obstructive Sleep Apnea Severity and N-Terminal Pro-B-Type Natriuretic Peptide Levels in Women.
- Frequency and Practice Level Variation In Inappropriate and Non-recommended Prasugrel Prescribing: Insights from the NCDR(®)PINNACLE Registry.
- Effects of Fenofibric Acid on Carotid Intima-Media Thickness in Patients With Mixed Dyslipidemia on Atorvastatin Therapy: Randomized, Placebo-Controlled Study (FIRST).
- Effects of the high-density lipoprotein mimetic agent CER-001 on Coronary atherosclerosis in patients with acute Coronary syndromes: a randomized trial.
- Decrease the incentives to order lipid panels-reply.
- High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study.
- Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African Americans.
- A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia.
- Revascularization improves mortality in elderly patients with Acute myocardial infarction complicated by cardiogenic shock.
- Neck Circumference Is Not Associated With Subclinical Atherosclerosis in Retired National Football League Players.
- Rare LPL gene variants attenuate triglyceride reduction and HDL cholesterol increase in response to fenofibric acid therapy in individuals with mixed dyslipidemia.
- Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk for Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
- Whole-Exome Sequencing Identifies Rare and Low-Frequency Coding Variants Associated with LDL Cholesterol.
- Troponin T, NT-proBNP, and venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE).
- Long-term effects of maximally intensive statin therapy on changes in Coronary atheroma composition: insights from SATURN.
- Attenuated adipose tissue and skeletal muscle inflammation in obese mice with combined CD4+ and CD8+ T cell deficiency.
- Age and Sex Dependent Upper Reference Limits for the High Sensitivity Cardiac Troponin T Assay.
- APOE Modulates the Correlation Between Triglycerides, Cholesterol, and CHD Through Pleiotropy, and Gene-by-Gene Interactions.
- The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT).
- C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive...
- Three-year variability in plasma concentrations of the soluble receptor for advanced glycation end products (sRAGE).
- Sleep Apnea is Associated with Subclinical Myocardial Injury in the Community: The ARIC-SHHS Study.
- The Editor's Roundtable: Hypertriglyceridemia.
- Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholes...
- Association between statins and infections after coronary Artery bypass grafting.
- NH2-Terminal Pro-Brain Natriuretic Peptide and Risk of Diabetes.
- Application of speckle-tracking in the evaluation of Carotid artery function in subjects with hypertension and diabetes.
- Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy.
- Single Nucleotide Polymorphisms in Cholesteryl Ester Transfer Protein Gene and Recurrent Coronary Heart Disease or Mortality in Patients With Established Atherosclerosis.
- Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy.
- Patients with severe chronic kidney Disease benefit from early revascularization after acute coronary syndrome.
- Lipoprotein-associated phospholipase A2 and venous thromboembolism: A prospective study.
- Cardiovascular biomarkers and subclinical brain Disease in the atherosclerosis risk in communities study.
- Retinol binding protein 4 and incident diabetes - the Atherosclerosis Risk in Communities Study (ARIC Study).
- Icosapent ethyl for the treatment of hypertriglyceridemia.
- Comparison by Meta-Analysis of Mortality After Isolated Coronary Artery Bypass Grafting in Women Versus Men.
- Factors underlying regression of Coronary atheroma with potent statin therapy.
- Troponin T, N-terminal pro-B-type natriuretic Peptide, and incidence of stroke: the atherosclerosis risk in communities study.
- Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: From the look AHEAD study.
- Association Between Preoperative Diuretic Use and In-hospital Outcomes After Cardiac Surgery.
- Combined Association of Creatinine, Albuminuria, and Cystatin C with All-Cause Mortality and Cardiovascular and Kidney Outcomes.
- Trans-ethnic fine-mapping of lipid Loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained.
- Lactate and Risk of Incident Diabetes in a Case-Cohort of the Atherosclerosis Risk in Communities (ARIC) Study.
- Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European americans and blacks: a meta-analysis from atherosclerosis risk in com...
- Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality.
- Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies.
- sRAGE and risk of diabetes, cardiovascular Disease and death.
- Diabetes medication use and blood lactate level among participants with type 2 diabetes: the atherosclerosis risk in communities Carotid MRI study.
- A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier Disease.
- Novel risk factors and the prediction of type 2 diabetes in the Atherosclerosis Risk in Communities (ARIC) study.
- Alteration of Relation of Atherogenic Lipoprotein Cholesterol to Apolipoprotein B by Intensive Statin Therapy in Patients With Acute Coronary Syndrome (from the Limiti...
- Non-high-density lipoprotein cholesterol reporting and goal attainment in primary care.
- Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study).
- Adiponectin and the mediation of HDL cholesterol change with improved lifestyle: The Look AHEAD Study.
- Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study).
- Outcomes of Preoperative Angiotensin-Converting Enzyme Inhibitor Therapy in Patients Undergoing Isolated Coronary Artery Bypass Grafting.
- ApoE and the role of very low density lipoproteins in adipose tissue inflammation.
- Racial Differences in Association of Elevated Interleukin-18 Levels With Type 2 Diabetes: The Atherosclerosis Risk in Communities Study.
- Lifestyle Modification with Diet and Exercise in Obese Patients with Heart Failure - A Pilot Study.
- LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.
- Association of gender with morbidity and mortality after isolated coronary Artery bypass grafting. A propensity score matched analysis.
- Treatment Gaps in Adults with Heterozygous Familial Hypercholesterolemia in the United States: Data from the CASCADE-FH Registry.
Schools
Baylor University
University Tex Sw
Baylor College Of Med
Procedures Preformed
- Cardiac Imaging
- Chest CT (incl. Heart and Lungs)
Conditions Treated
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- Carotid Artery Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- Elected Member
- Fellow (FACC)
- Whos Who in Medicine and Healthcare
Education
-
Baylor College of Medicine
Drug Facts
| NPI NUMBER | 1467471557 | |
| NPPES Provider LastName | BALLANTYNE | |
| NPPES Provider FirstName | CHRISTIE | |
| NPPES Provider ZIPCode | 77030 | |
| NPPES Provider State | TX | |
| Specialty Description | Cardiology | |
| Total Claim Count | 427.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467471557 |
| Last Name Of The Provider | BALLANTYNE |
| First Name Of The Provider | CHRISTIE |
| View All |
Similar Doctors
|
|
Dr. Allison M. Pritchett, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amit A. Zachariah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Samuels, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jianwei Feng, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sayed F. Feghali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose Banchs, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ali E. Denktas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Guha Ashrith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ijeoma E. Ananaba, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Enrique A. Hernandez Vila, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francisco J. Cota, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brinder S. Kanda, MD |
|
|
Dr. David Paniagua, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Juan Carlos Rozo, MD
This Doctor is OpenDoctor Recommended.
|